Nuwellis revenue grows 14% in second quarter
Nuwellis (NASDAQ:NUWE), a medical technology company focused on cardiorenal solutions, reported preliminary second-quarter 2026 revenue growth of 14% year over year and first-half 2026 revenue growth of 20%.


_1447169_640x360_2508609603994-640x360.webp&w=3840&q=75)
_1447162_640x360_2508610115951-640x360.webp&w=3840&q=75)





_1447140_640x360_2508602947742-640x360.webp&w=3840&q=75)

